Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), SRC inhibitors(Tyrosine-protein kinase SRC inhibitors), VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | CN | 09 Feb 2015 |